AzTrials
AzTrials

Vaping BehaviorNCT05985538

Impact of E-Cigarette Prevention Messages on Adolescents

A study testing Vaping prevention text messages and Wellness behaviors text messages in people with Vaping Behavior, run by UNC Lineberger Comprehensive Cancer Center at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this trial is to determine whether a vaping prevention text message program reduces susceptibility to vaping among adolescents and young adults. This study addresses this issue by exposing participants to a vaping prevention text message program over a 28-day period in a randomized controlled trial with… Read more about this study

Who is it for?
Ages 13 to 20 yearsHealthy volunteers can take part
Conditions the study is for
Vaping Behavior
What is being tested?
Vaping prevention text messages and Wellness behaviors text messages
Could I receive a placebo?
No, everyone receives an active treatment
How many people
480 participants
Where
1 siteUnited States
Study dates
5 Feb 2024to 12 Aug 2024
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 20 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Ages 13-20 years old (inclusive)
  • Have a phone that sends and receives text messages
  • Ever vaped or are susceptible to using e-cigarettes or vaping

Who cannot join

  • None

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of North Carolina, Chapel Hill

    Chapel Hill, North Carolina, 27599

Other trials in United States

About this study

The purpose of this trial is to determine whether a vaping prevention text message program reduces susceptibility to vaping among adolescents and young adults. This study addresses this issue by exposing participants to a vaping prevention text message program over a 28-day period in a randomized controlled trial with a matched attention control condition. A follow-up assessment is also made 4 weeks after the text messaging ends.

Read the detailed description

Tobacco prevention communication is a key tool for reducing tobacco use among adolescents and young adults. While the use of e-cigarettes and vaping has increased greatly among adolescents and young adults, there has been a dearth of research on effective communication strategies to reduce vaping. This study will test the impact of a text-messaging program on reducing susceptibility to vaping in a randomized controlled trial, illuminating whether such programs can be effective. The investigators focus on adolescents and young adults (ages 13-20) who currently vape or who are at risk of vaping.

Participants will be randomly assigned to receive either a vaping prevention text message program or a wellness text message program (control). Participants in the study will take 4 online surveys over an 8-week period - at Visit 1 (baseline), Visit 2 (2 weeks), Visit 3 (4 weeks), and Visit 4 (8 weeks).

Conditions
Vaping Behavior
Being tested
Vaping prevention text messages, Wellness behaviors text messages
Keywords
Health communication, Tobacco use, vaping prevention
Medical subject headings
Tobacco Use

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Vaping prevention text messagesBehavioural

    Participants will receive text messages (2 daily, on average) about the harms of e-cigarette use and vaping for 28 days, with introductory messages sent on day 1 and concluding messages sent on day 28. Each vaping prevention text message will focus on one of six topics: nicotine addiction, monetary costs of vaping, chemical exposures from e-cigarette vapor, cosmetic effects of vaping, mental and physical use symptoms of vaping, and health impact on organs from vaping. Some text messages will ask participants for a reply (i.e., two-way messages).

  • Wellness behaviors text messagesBehavioural

    Participants will receive text messages (2 daily, on average) about general wellness topics, with introductory messages sent on day 1 and concluding messages sent on day 28. Each wellness text message will focus on one of six topics: sleep hygiene, safe driving, sun safety, study habits, nutrition, and exercise. This attention control condition is matched with the intervention condition in that participants will receive the same number of text messages over the same number of days, the same intervention structure (e.g., 6 topics), and the same number and types of two-way messages.

Study groups in NCT05985538
Study groupRoleWhat they receive
Vaping prevention text messagesExperimentalParticipants will receive text messages (2 daily, on average) about the harms of e-cigarette use and vaping for 28 days, with introductory messages sent on day 1 and concluding messages sent on day 28.
Receives: Behavioral: Vaping prevention text messages
Wellness behavior text messagesActive comparatorParticipants will receive text messages (2 daily, on average) about general wellness topics, with introductory messages sent on day 1 and concluding messages sent on day 28.
Receives: Behavioral: Wellness behaviors text messages

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean Susceptibility to Vaping Score

    The mean susceptibility to vaping score will be assessed using the questionnaire. Response options are on a 1 to 4 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-4), with higher scores representing a greater susceptibility to vaping (a worse outcome).

    Measured: Visit 3 (4 weeks)

Secondary outcomes (19)
  1. Mean Vaping Instrumental Attitudes Score

    The mean vaping instrumental attitudes score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing a belief that vaping is more beneficial, safe and healthy.

    Measured: Visit 3 (4 weeks)

  2. Mean Vaping Affective Attitudes Score

    .The mean vaping affective attitudes score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing a belief that vaping is more enjoyable, pleasant, and fun.

    Measured: Visit 3 (4 weeks)

  3. Mean Vaping Addiction Risk Beliefs Score

    The mean vaping addiction risk beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing more tendency to addiction.

    Measured: Visit 3 (4 weeks)

  4. Mean Vaping Monetary Cost Beliefs Score

    The mean vaping monetary cost beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores represents participants' believes that vaping is a costly activity.

    Measured: Visit 3 (4 weeks)

  5. Mean Vaping Chemical Risk Beliefs Score

    The mean vaping chemical risk beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing participant's believes that e-cigarette vapor contains chemicals that pose health risks.

    Measured: Visit 3 (4 weeks)

  6. Mean Vaping Cosmetic Risk Beliefs Score

    The mean vaping cosmetic risk beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing participant belief that use will harm their cosmetic appearance.

    Measured: Visit 3 (4 weeks)

  7. Mean Vaping Health Symptoms Beliefs Score

    The mean vaping physical symptoms of use beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores represent participant believes that e-cigarette use will cause certain physical symptoms.

    Measured: Visit 3 (4 weeks)

  8. Mean Vaping Mental Health Symptoms of Use Beliefs Score

    The mean vaping mental health symptoms of use beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores represent participant believes that e-cigarette use will cause or worsen mental health symptoms.

    Measured: Visit 3 (4 weeks)

  9. Mean Vaping Health Organ Risk Beliefs Score

    The mean vaping health organ risk beliefs score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing participant believes that e-cigarette use will harm the health of certain organs.

    Measured: Visit 3 (4 weeks)

  10. Mean Susceptibility to Smoking Cigarettes Score

    The mean susceptibility to smoking cigarettes score will be assessed using the questionnaire. Response options are on a 1 to 5 scale. Overall scale scores are determined by summing scores of the 3 items and dividing them by 3 (range 1-5), with higher scores represent participant more open to smoking.

    Measured: Visit 3 (4 weeks)

  11. Mean Smoking Instrumental Attitude Score

    The 1-item mean smoking instrumental attitude measure assesses a participant's attitude toward smoking. Response options are on a 1 to 5 scale, with higher scores representing a more harmful perception of smoking.

    Measured: Visit 3 (4 weeks)

  12. Mean Smoking Affective Attitude Score

    The 1-item mean smoking affective attitude measure assesses a participant's attitude toward smoking (unenjoyable/enjoyable). Response options are on a 1 to 5 scale, with higher scores representing a more enjoyable attitude toward smoking.

    Measured: Visit 3 (4 weeks)

  13. Mean Smoking Addiction Risk Belief Score

    The 1-item mean smoking addiction risk belief measure assesses the extent to which a participant believes that smoking will lead to addiction. Response options are on a 1 to 5 scale, with higher scores representing beliefs that smoking will lead to addiction.

    Measured: Visit 3 (4 weeks)

  14. Mean Smoking Health Harm Risk Belief Score

    The 1-item mean smoking health harm risk belief measure assesses the extent to which a participant believes that smoking will lead to health harm. Response options are on a 1 to 5 scale, with higher scores representing higher beliefs that smoking will cause to health harm.

    Measured: Visit 3 (4 weeks)

  15. Mean Vaping Injunctive Norms Score

    The 3-item mean vaping injunctive norms scale assesses a participant's perception of others' approval or disapproval of their vaping behavior. Response options are on a 1 to 5 scale. Overall scores are determined by summing the scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing a participant's perception of others' approval about vaping.

    Measured: Visit 3 (4 weeks)

  16. Mean Vaping Refusal Self-efficacy Score

    The 3-item mean vaping refusal self-efficacy scale assesses a participant's confidence that they could refuse to vape in a social situation. Response options are on a 1 to 5 scale. Overall scores are determined by summing the scores of the 3 items and dividing them by 3 (range 1-5), with higher scores representing a higher amount of refuse to vape in a social situation.

    Measured: Visit 3 (4 weeks)

  17. Frequency of Vaping

    Participants will be asked the number of days they vaped over the past 30 days, with higher scores indicating more days vaped.

    Measured: Visit 3 (4 weeks)

  18. Frequency of Cigarette Smoking

    Participants will be asked the number of days they smoked cigarettes over the past 30 days, with higher scores indicating more days smoked.

    Measured: Visit 3 (4 weeks)

  19. Frequency of Using Other Tobacco Products

    Participants will be asked if they used other tobacco products (OTP) over the past 30 days. OTP use will be determined as follows: no use = person who doesn't use OTPs; used = person who uses OTPs; no response = person who skipped or refused to answer

    Measured: Visit 3 (4 weeks)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Aug 2023
  2. Study start5 Feb 2024
  3. Primary completion12 Aug 2024
  4. Study completion12 Aug 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
480 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05985538
Sponsor's protocol ID
20-1245
Other IDs
5R01DA049155-02
Status last verified
Aug 2025
First submitted
2 Aug 2023
Last updated
6 Oct 2026
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Vaping prevention text messages and Wellness behaviors text messages in people with Vaping Behavior, run by UNC Lineberger Comprehensive Cancer Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 22 Aug 2025). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean Susceptibility to Vaping Score (time frame: Visit 3 (4 weeks)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Oct 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in